February 23rd 2023
February 23rd 2023
Are Oncology Clinical Pathways a Value Framework in the Making?
April 18th 2016Evidence-Based Oncology invited a panel of experts who are experienced in the creation of oncology care pathways, use them in their practice, and have researched the development and implementation of care pathways, to exchange ideas on the topic.
Read More
Clinical Pathways: A Systems Approach Toward More Patient-Centric Cancer Care Delivery
April 16th 2016Despite the fundamental advances in cancer care technology and care delivery that have made these improvements possible, our delivery system remains quite inefficient and frequently falls short of being truly patient-centered. Is a system-based solution the answer?
Read More
Recommendations for the Role of Clinical Pathways in an Era of Personalized Medicine
We offer recommendations for the development and design of clinical pathways in an effort to establish a set of normative criteria that creates trust and transparency.
Read More
ASCO Policy Statement on Clinical Pathways in Oncology: Why Now?
April 11th 2016Members of the American Society of Clinical Oncology (ASCO) have articulated concerns regarding the current proliferation of clinical pathways in oncology that could affect patient access and care quality. In response, ASCO established an ad hoc Task Force, which issued a policy statement to guide the future development and implementation of these treatment management tools.
Read More
Care Pathways in US Healthcare Settings: Current Successes and Limitations, and Future Challenges
Care pathways influence quality of care and outcomes. Despite positive trends in development and implementation, further efforts in process transparency and evaluation are required.
Read More
Is There a Mathematical Resolution to the Cost-Versus-Value Debate?
December 11th 2015Solutions proposed by patient advocates and physicians to control costs provide approaches to valuing new drug/treatments compared with 1 or several prevailing standards of care. Increasingly, however, the debate over cost is transitioning to a debate over value.
Read More
Developing Evidence That Is Fit for Purpose: A Framework for Payer and Research Dialogue
A decision-making framework that can be used to harmonize the evidence payer's desire for coverage and formulary decisions with the evidence generated by researchers.
Read More
Precision Oncology: Are Payers on the Right Pathway?
August 4th 2015In oncology, the shift from a "companion diagnostic" to a "companion therapeutic" paradigm is in high gear. While the noise and confusion is leading many payers to avoid coverage, they can benefit by proactively taking steps to integrate precision oncology to better manage quality, access, and cost of cancer care.
Read More
Clinical Pathways Increasing Used, but Concerns Remain
July 30th 2015Clinical pathways (CPs) are increasingly being utilized to improve quality of care and control healthcare costs in the United States. A new report from Avalere Health examines the development of CPs, use of evidence to inform their design, implementation processes, and their impact on quality of care, costs, and outcomes.
Read More
In AJMC, Brookings Authors Discuss Applying New Payment Models to Oncology
May 19th 2015The realm of cancer care remains a holdout in the movement toward value-based payment models, with implications for cost and health outcomes, according to authors of a new article in The American Journal of Managed Care. Authors from the Center for Health Policy at the Brookings Institution assert that new payment models can be adopted by all payer and provider types, with benefits over the traditional fee-for-service model.
Read More
Dr Robert W. Dubois Explains the Growing Importance of Clinical Pathways
April 9th 2015Pathways, particularly in oncology, have been gaining a lot more attention lately as payers are looking to bundle payments, Robert W. Dubois, MD, PhD, chief science officer and executive vice president of the National Pharmaceutical Council, explained at the Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo in San Diego, April 7-10.
Watch
Balancing Value, Pathways, and Innovation in Healthcare
February 18th 2015As specialty drug costs, formulary wars, and reimbursement models grab headlines everyday, we need to take a step back and visualize how all of this might impact innovation and whether the patient stands to lose in the process.
Read More